Malaysian Palm Oil Board
Kajang, Selangor, 43000, Malaysia
NCT Number: NCT01124487
Objectives: To investigate the acute effects of olive oil, palm olein and lard on lipid profile, insulin sensitivity and inflammatory markers.
Hypothesis: Different dietary fats will alter lipid profile, insulin sensitivity and inflammatory markers postprandially.
Looking for future studies?
Notify Me18 year–45 year
Male
Interventional
Not applicable
Kajang, Selangor, 43000, Malaysia
A randomized, single blind, crossover design was undertaken to test meals enriched with palm olein vs olive oil vs lard. Volunteers were asked to participate in three postprandial challenges, separated by at least 3-days. Subjects were provided a low fat meal(<10g fat) the day before the intervention. Fasting blood was collected the next day and the subjects were instructed to consume test meals (50g high fat meal). Further venous blood was collected at 30 min, 1h, 2h, 3h and 4h postprandially.
Primary outcome variable: Triacylglycerol (TAG) Secondary outcome variables: Insulin sensitivity (glucose, insulin), non esterified fatty acids (NEFA), inflammatory markers
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 4 h
Time frame: 4 h
Malaysia Palm Oil Board
Other Gov
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06961110
Autonomic Nervous System Activity, Body Composition
Olomouc, Czech Republic, Czechia
View Trial DetailsNCT06949709
Blood Pressure, Glucose Levels
Taipei, Taiwan
View Trial DetailsNCT04084847
Blood Pressure, Cardiovascular Risk Factor
Tehran, Iran
View Trial DetailsNCT02183922
Anthropometric Measure, Blood Pressure
Rio de Janeiro, Brazil
View Trial Details